Discovery | Charles River

Discovery Services has joined IQVIA Laboratories. This exciting evolution brings together our trusted scientific teams, deep expertise, and innovative technologies with an expanded network of data, technology, and development capabilities. Together, we’re better positioned than ever to support our clients’ discovery and development goals. Starting in July 2026, all discovery-focused content will be published through IQVIA Laboratories. Follow IQVIA Laboratories for the latest scientific perspectives, industry updates, and company news: https://okt.to/JF1QdT

Discovery Services is now part of IQVIA Laboratories. While our name has evolved, our commitment remains the same. The teams, scientific expertise, and technologies you trust continue to support clients, now strengthened by access to IQVIA Laboratories’ broader ecosystem of data, technology, and development resources. Beginning in July 2026, discovery-related updates and content will be shared through IQVIA Laboratories. Follow IQVIA Laboratories to stay connected with the latest scientific insights, news, and announcements: https://okt.to/FIm0go

🎉 A major milestone for our Reno, Nevada site: the expansion of our bioanalytical testing capacity with the addition of 5,000 square feet of new laboratory space. “Today marks yet another exciting milestone for our Reno site,” said Brad Saville, General Manager, Reno. “This new space strengthens our ability to meet the growing demand for nonclinical and clinical bioanalytical services and increase our automation footprint. We are excited to leverage this investment to advance the development of novel therapeutics with speed, flexibility, and scientific excellence.” Thank you to our Reno team and the Charles River leadership who joined us for the ribbon-cutting celebration and helped make this milestone possible. Ready to discuss your bioanalytical needs? Connect with our experts to explore how we can support your program: https://okt.to/h4iA0m #CharlesRiver #Bioanalysis #DrugDevelopment #ScientificExcellence #TeamCharlesRiver #LigandBindingAssays #ClinicalResearch #Biopharma

Discovery Services is now part of IQVIA Laboratories. Our teams, scientific expertise, and technologies remain committed to supporting clients and are now enhanced by a broader ecosystem of technology, data, and development resources. Starting July 2026, new discovery-related content will be shared at IQVIA Laboratories. Follow IQVIA Laboratories to stay updated with scientific insights, news, and announcements: https://okt.to/eaWLlA

You still have one more day to chat with our team at Booth #01 at the International Society for the Study of Xenobiotics Meeting in Basel. Drop by to discuss ADME-Tox with our experts and visit the team's posters on in vitro metabolism and hepatocyte systems: P69 by Merel Post and P79 by Johanna Pacsuta. Big thanks to everyone who listened to Zsolt Fekete's thought leadership talk. Click to learn more about our capabilities: https://bit.ly/4oYaIqI

Visit us at Booth #1 and hear about our latest ADME-Tox research at the 16th International Society for the Study of Xenobiotics European meeting in Basel between June 29 and July 2. Make sure to attend our Thought Leadership Presentation by Zsolt Fekete on July 1, and visit our poster presentations by Merel Post and Johanna Pacsuta (in collaboration with Semmelweis University)! Meet the team: https://bit.ly/3QBTdA3

Watch now to unlock more predictive, long-term hepatotoxicity insights with next-generation 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 liver models that maintain functionality for weeks, not just hours. In this webinar, our experts, Zsuzsanna Gáborik and Johanna Pacsuta, walk you through the latest tools for more reliable DILI assessment without added complexity. Click for the on-demand recording: https://bit.ly/4eS6YDN #hepatotoxicity #invitrotoxicity #hepatocyte #livertox #ADME #DMPK #DILI #invitroADME #pharmawebinar #drugdevelopment #spheroid #liverspheroid #liverculture #drugmetabolism #drugtransporter

Join us for a focused, in-person lunch session to explore how 𝗡𝗲𝘄 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗠𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 (𝗡𝗔𝗠𝘀) are reshaping drug safety testing, influencing regulatory strategy, and helping teams make faster, more confident development decisions. We’re creating a space for open dialogue on this exciting topic, and your voice will help drive the conversation forward. 𝗔𝗚𝗘𝗡𝗗𝗔: 11:30-11:45: Welcome & Registration Sign-in and Pick-up Lunch 11:45-12:00: Introduction: Charles River - Your partner every step of the way (Sabine Gorynia PhD, Regional General Manager, Corporate VP) 12:00-12:15: NAMs Fever, Cutting through the Hype and Misconceptions (Sarah Gould PhD, Director, Senior Principal Scientific Advisor, Scientific Advisory Services) 12:15-12:40: Reshaping Nonclinical Safety Programs with NAMs Integration (Pramila Singh, PhD DABT, Senior Principal Scientific Advisor, Scientific Advisory Services) 12:45-13:10: Exploring NAMs Context of Use in Biopharmaceutical Development (Sarah Gould PhD) 13:15-13:45: Interactive Coffee Break 13:45-14:10: NAMs Applications using 𝗥𝗲𝘁𝗿𝗼𝗴𝗲𝗻𝗶𝘅® 𝗖𝗲𝗹𝗹 𝗠𝗶𝗰𝗿𝗼𝗮𝗿𝗿𝗮𝘆 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 (Mark Aspinall-O'Dea PhD, Cell-Based Innovation Lead) 14:15-14:45: Interactive Panel Discussion with Q&A To 𝘀𝗮𝘃𝗲 𝘆𝗼𝘂𝗿 𝘀𝗲𝗮𝘁, reach out directly to Nitin Sabherwal, PhD (BDE, Europe) either via LinkedIn OR through email (Nitin.Sabherwal@crl.com).

We are proud to be sponsoring the 16𝐭𝐡 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 International Society for the Study of Xenobiotics 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 in Basel, Switzerland. Meet our 𝐀𝐃𝐌𝐄-𝐓𝐨𝐱 𝐞𝐱𝐩𝐞𝐫𝐭 𝐭𝐞𝐚𝐦 𝐚𝐭 𝐁𝐨𝐨𝐭𝐡 #1 to learn more about our solutions for confident, data-driven decisions, wherever you are in your development journey. Make sure to visit our posters, and don't miss our lunchtime 𝐓𝐡𝐨𝐮𝐠𝐡𝐭 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 on July 1st, addressing Fit-for-purpose 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 metabolism solutions. 𝐌𝐞𝐞𝐭 𝐭𝐡𝐞 𝐭𝐞𝐚𝐦: https://bit.ly/4vfwJE2  #ISSX #ISSX2026 #ADME #DMPK #ADMET #Drugdevelopment #Drugdiscovery #Drugmetabolism #Retrogenix #Invitrotox #ICHM12

Can you trust long‑term liver safety data generated with short‑lived hepatocyte models? Join our experts Zsuzsanna Gáborik and Johanna Pacsuta for a live webinar to learn about next‑generation in vitro systems that extend studies from hours to weeks. Click to book your spot: https://bit.ly/4uwVV8t You can also address your questions to our scientists during a live Q&A session after the presentation. #hepatotoxicity #livertoxicity #DILI #spheroids #invitromodels #drugtoxicity #ADME #DMPK #hepatocytes #drugsafety #NAMs #3Rs